Clinical trial • Respiratory
Clinical trial in Chronic Obstructive Pulmonary Disease
Clinical trial for Chronic Obstructive Pulmonary Disease. Randomised, crossover. 60 participants.
Overview
- Trial Therapeutic Area
- Respiratory
- Trial Disease
- Chronic Obstructive Pulmonary Disease
- Drug Modality
- Small molecule
Key dates
- Initial CTIS Submission Date
- 15-10-2025
- First CTIS Authorization Date
- 19-01-2026
Trial design
Randomised, crossover trial across 1 site in Belgium.
- Randomised
- Yes
- Crossover
- Yes
- Target Sample Size
- 60
- Trial Duration For Participant
- 120
Eligibility
Recruits 60 Vulnerable populations not selected; no assent/consent details provided..
- Vulnerable Population
- Vulnerable populations not selected; no assent/consent details provided.
Recruitment
- Planned Sample Size
- 60
- Recruitment Window Months
- 4
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 60
Belgium
- Earliest CTIS Part Ii Submission Date
- 15-12-2025
- Latest Decision Or Authorization Date
- 19-01-2026
- Processing Time Days
- 35
- Number Of Sites
- 1
- Number Of Participants
- 60
Sites
- Site Name
- CHU Saint Pierre
- Department Name
- Pulmonology
- Contact Person Name
- Koen Verbeke
- Contact Person Email
- koen.verbeke@stpierre-bru.be
- Number Of Participants
- 60
Sponsor
Primary sponsor
- Full Name
- CHU Saint Pierre
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Belgium
Related trials
Other published trials that may interest you.
- AZITHROMYCIN DIHYDRATE for Chronic obstructive pulmonary disease
- DEPEMOKIMAB for Chronic obstructive pulmonary disease
- 6-THIO-ALFA-D-GLUCOPYRANOSYL 6-THIO-ALFA-D-GLUCOPYRANOSIDE for Chronic obstructive pulmonary disease
- DUPILUMAB for Chronic obstructive pulmonary disease
- METFORMIN HYDROCHLORIDE for Chronic obstructive pulmonary disease